Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03157128
Title Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Loxo Oncology, Inc.
Indications

thyroid gland cancer

thyroid gland medullary carcinoma

pheochromocytoma

Advanced Solid Tumor

Therapies

Selpercatinib

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST